Navigation Links
Hepatitis C Occurs Even After Liver Transplantation

The serum viral levels fall after the removal of a diseased liver from a Hepatitis C (HCV) patient. Virus levels are found to return even after a healthy liver transplant, which can even go beyond pre-transplant levels, // according to a new research results published in the American Association for the Study of Liver Diseases’ (AASLD) Liver Transplantation journal. The chief reason for most liver transplantations is Hepatitis C.

As many as six liver transplant patients who had undergone cadaveric liver transplants as result of HCV infection were studied by the team of researchers. The levels of the HCV RNA were measured for changes with blood tests before, during and after the transplant operation utilizing the reverse transcription polymerase chain reaction assay, and linear regression was used to analyze the results.

It was seen that the HCV RNA levels fell in the case of most patients during the course of the transplantation operation, which rose subsequently afterwards, until a level which is above the pre-transplantation level is attained, in some cases growing by 100% every 2 days.

In the case of three patients there was a plateauing of the level before rising. As much as 4% of the viral production is from non-hepatic sources, while the liver accounts for the balance 96%, which goes to prove that the primary viral replication takes place in the liver. The virion half-life seen in this study is very much higher than what has been observed in previous studies, even though the rise and fall of the viremia appears to be the same.
'"/>




Page: 1

Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Need for Hepatitis Booster Questioned
9. Good News for HIV Patients Also Suffering From Hepatitis C Virus
10. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
11. The Effectiveness Of Hepatitis B Vaccine Questioned
Post Your Comments:
Other Medicine News:Health News:Is There Really Such a Thing as Hope in a Jar? 2Health News:Is There Really Such a Thing as Hope in a Jar? 3Health News:Is There Really Such a Thing as Hope in a Jar? 4Health News:Is There Really Such a Thing as Hope in a Jar? 5Health News:CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions 2Health News:CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions 3Health News:CDC Reports Drop in Adult Smoking, But Death Toll and Health Costs Are Still Growing; Congress, States Should Implement Proven Solutions 4Health News:Elizabeth Edwards Reschedules Metro Detroit Appearance 2Health News:HIV Vaccine Failure Still Brings Insights 2Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 2Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 3Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 4Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 5Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 6Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 7Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 8Health News:Misonix Reports First Quarter Fiscal Year 2009 Financial Results 9Health News:Relationship between prostate information and lower urinary-tract symptoms evident 2
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Major Biotechnology Franchise Company Expands Rapidly Throughout the USA Amidst Mounting Health Concerns 61042 1Major Biotechnology Franchise Company Expands Rapidly Throughout the USA Amidst Mounting Health Concerns 61042 2WAVE 26apos 3Bs Revolutionary Whole Body Advanced Vibration Exercise Is Now Available in South America 61038 1WAVE 26apos 3Bs Revolutionary Whole Body Advanced Vibration Exercise Is Now Available in South America 61038 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 1Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 3Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 4